This HTML5 document contains 149 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n7https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34570658
rdf:type
wikibase:Item
schema:description
научни чланак 2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած 2009年の論文 научни чланак 2009年论文 vetenskaplig artikel artikull shkencor artigo científico (publicado na 2009) artykuł naukowy 2009年論文 artículo científico publicado en 2009 2009年论文 vědecký článek vedecký článok videnskabelig artikel (udgivet 2009) სამეცნიერო სტატია artigo científico научная статья articolo scientifico naučni članak 2009 nî lūn-bûn scienca artikolo مقالهٔ علمی 2009年论文 مقالة علمية bài báo khoa học scientific article article scientifique (publié 2009) artigo científico (publicado na 2009) επιστημονικό άρθρο mokslinis straipsnis wetenschappelijk artikel 2009年論文 artículu científicu espublizáu en 2009 2009年论文 2009년 논문 мақолаи илмӣ vitskapeleg artikkel bilimsel makale מאמר מדעי мақолаи илмӣ научна статия wissenschaftlicher Artikel articol științific سائنسی مضمون 2009年論文 teaduslik artikkel tudományos cikk vitenskapelig artikkel 2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված artikulong pang-agham ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2009年論文 2009年论文 บทความทางวิทยาศาสตร์ 2009年論文 tieteellinen artikkeli 2009年论文 article científic article scientific наукова стаття, опублікована в грудні 2009
p:P577
wds:Q34570658-B273B593-A2A2-421B-9563-7C4EFD703855
wdt:P577
2009-12-09T00:00:00Z
p:P2888
wds:Q34570658-5291BC3F-FCFC-43D1-8F47-C564DEC22DE8
wdt:P2888
n7:s10637-009-9364-z
p:P2860
wds:Q34570658-DB03C6D7-55D8-4674-A0D7-EEA467B50565 wds:Q34570658-92729AA1-0142-4CD2-A6FF-D8F60C6EC44F wds:Q34570658-63F2C853-8C70-4D97-B9C0-DB2C17D7C501 wds:Q34570658-6554CEFB-5556-4003-A0C6-2C8EB1DC65D9 wds:Q34570658-6CB701A4-58DD-4F6B-930B-949E78820EEC wds:Q34570658-72589ED7-545D-4702-A2CA-1E150B61E701 wds:Q34570658-C0488D13-8F14-47C6-A366-3514FFC2B343 wds:Q34570658-AC4DFC83-0E1F-4C15-AB84-15776B9947C2 wds:Q34570658-177C5023-49AF-48F3-9E1C-E19EB134AD52 wds:Q34570658-18D68455-A3F2-4213-93EE-92ED09FEA425 wds:Q34570658-152CD70F-1886-4B76-BA8D-C72A860543EA wds:Q34570658-1634D580-22B2-446A-A850-15AE46B7E123 wds:Q34570658-39AC675A-B66A-4C68-BC14-6DF5C27041A2 wds:Q34570658-60A73D0B-BC8F-41C4-98E2-611F09045DC6 wds:Q34570658-2BABF55D-2349-48D6-A503-114045520D6E wds:Q34570658-D66BDB1A-0BE9-46A4-B7B5-CE96B6E12345
wdt:P2860
wd:Q40511894 wd:Q28567883 wd:Q40775560 wd:Q36656693 wd:Q40403275 wd:Q35997232 wd:Q34341697 wd:Q30662282 wd:Q69840251 wd:Q35164078 wd:Q37257417 wd:Q34914751 wd:Q71235540 wd:Q36250951 wd:Q40427675 wd:Q37314555
p:P2093
wds:Q34570658-7F67B148-D55D-47DC-899F-6E293FA48479 wds:Q34570658-D6CAAF76-C8B7-4808-9E31-398D11614AB6 wds:Q34570658-EE471993-AF97-47DC-9021-44D2D1E5B7F0 wds:Q34570658-03DD5732-E5F3-4A57-9258-BE3A5B48551A wds:Q34570658-1993192E-3E2B-4878-91DF-1A47DE23154B wds:Q34570658-24D8A437-E99A-48A3-AEA5-8881A5EAE846
wdt:P2093
Howard H Bailey Dona Alberti Tarak D Mody Anne M Traynor Ramesh K Ramanathan James P Thomas
rdfs:label
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
skos:prefLabel
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
schema:name
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
p:P50
wds:Q34570658-9B381711-784D-4113-A590-CB9AA66382E1
wdt:P50
wd:Q5546267
p:P1476
wds:Q34570658-CD810891-376A-409B-B252-4921D2F8C78C
wdt:P1476
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
p:P304
wds:Q34570658-22E4928A-85EC-4E64-97CE-DB06FCB64C06
wdt:P304
316-322
p:P31
wds:Q34570658-D26E2BA3-EFF9-4173-A0F1-2435D8DC3DC8
wdt:P31
wd:Q13442814
p:P921
wds:Q34570658-346D27E8-207D-417E-A4CB-19EAC4F592E1 wds:Q34570658-15CB3303-9F3D-4320-B2F6-BC9D421FD5E3
wdt:P921
wd:Q18936 wd:Q5452194
p:P698
wds:Q34570658-F8D044A1-6D86-44F1-8D5C-F8DE1AF6ED17
wdtn:P698
n9:19997959
wdt:P698
19997959
p:P1433
wds:Q34570658-3E2FA09B-F185-4CA2-8723-093B5B036616
wdt:P1433
wd:Q2312231
p:P433
wds:Q34570658-A5F50A6A-C4B8-438B-9CE0-09C7D9415127
p:P478
wds:Q34570658-1E4289BA-8FB9-49DE-966D-E6A8FA9D5485
wdt:P433
2
wdt:P478
29
p:P356
wds:Q34570658-997CE291-5185-4592-90B5-82F80151E2A2
wdtn:P356
n12:S10637-009-9364-Z
wdt:P356
10.1007/S10637-009-9364-Z
p:P5875
wds:Q34570658-92E4B2AE-F0F3-4869-8E3F-39F43CCE9D5D
wdt:P5875
40484774
p:P6179
wds:Q34570658-B1D3C28F-AB4C-41DC-8200-CBE1BCF0B2FD
wdt:P6179
1022628502
p:P932
wds:Q34570658-BF033BE2-6737-411A-A221-3D26D4B1F65B
wdt:P932
3038176